Phargomed El Salvador
WhatsApp
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 98%, (99% ee)

Strem Chemicals

(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 98%, (99% ee)

N° de parte: 15-8638

Ligands | Catalysts | Other Reagents

Cotizar por WhatsApp
El producto (3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 98%, (99% ee) de la marca Strem Chemicals, es un reactivo especializado en la categoría de ligandos y catalizadores. Este compuesto es utilizado principalmente en investigaciones químicas y en procesos de síntesis en laboratorios, beneficiando a instituciones como hospitales, clínicas, universidades y laboratorios en El Salvador que requieren de reactivos de alta pureza para sus experimentos y desarrollos. Su alta pureza y especificidad lo hacen ideal para aplicaciones en química orgánica y catálisis, donde se busca optimizar reacciones y obtener resultados precisos. Phargomed El Salvador distribuye la marca Strem Chemicals con entrega en todo el país y ofrece soporte local para cualquier consulta. Se invita a los interesados a solicitar cotización en dólares a través de WhatsApp.

Productos relacionados

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-tricyclohexylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-tricyclohexylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%

(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee)

(11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee)